NeueHealth Inc. (NEUE)
NYSE NYSE Primary 
NeueHealth, Inc. (NEUE) Q2 2025 Earnings Call Transcript
NeueHealth, Inc. (NYSE:NEUE ) Q2 2025 Earnings Conference Call August 7, 2025 8:00 AM ET Company Participants Emily Lombardi - Corporate Participant George Lawrence Mikan - Vice Chairman, CEO & President Jay Stephen Matushak - Chief Financial Officer Operator Good morning. Thank you for attending today's conference call.
NeueHealth, Inc (NEUE) Q1 2025 Earnings Call Transcript
NeueHealth, Inc (NYSE:NEUE ) Q1 2025 Results Conference Call May 8, 2025 8:00 AM ET Company Participants Mike Mikan - President & Chief Executive Officer Jay Matushak - Chief Financial Officer Operator Good morning, and welcome to NeueHealth's First Quarter 2025 Earnings Conference Call. As a reminder, this call is being recorded.
NeueHealth, Inc (NEUE) Q4 2024 Earnings Call Transcript
NeueHealth, Inc (NYSE:NEUE ) Q4 2024 Results Conference Call March 20, 2025 8:00 AM ET Company Participants Emily Lombardi - Assistant Vice President Mike Mikan - President & Chief Executive Officer Jay Matushak - Chief Financial Officer Operator Good morning, and thank you for joining us for the NeueHealth Q4 2024 Earnings Conference Call. My name is Carlin.
Bronstein, Gewirtz & Grossman, LLC Encourages NeueHealth, Inc. (NEUE) Stockholders to Inquire about Securities Investigation
NEW YORK CITY, NY / ACCESSWIRE / January 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE) and New Enterprise Associates ("NEA") (: ). Investors who purchased NeueHealth and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NEUE.
The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into NeueHealth Inc. For Securities Fraud
LOS ANGELES, CA / ACCESSWIRE / January 15, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
NeueHealth Inc. Is Being Investigated For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / January 14, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into NeueHealth, Inc. For Securities Fraud
LOS ANGELES, CA / ACCESSWIRE / January 13, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
NeueHealth Inc Is Being Investigated For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / January 12, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against NeueHealth, Inc. (NEUE) And Encourages Stockholders to Reach Out
NEW YORK CITY, NY / ACCESSWIRE / January 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE) and New Enterprise Associates ("NEA") (: ). Investors who purchased NeueHealth and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NEUE.
The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into NeueHealth, Inc. For Securities Fraud
LOS ANGELES, CA / ACCESSWIRE / January 11, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
NeueHealth Inc Is Being Investigated For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / January 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into NeueHealth, Inc. For Securities Fraud
LOS ANGELES, CA / ACCESSWIRE / January 9, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
